Arvaya Healthcare share news, announcements and annual reports
BSE: 524723Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹106.85.
28 Oct: open ₹107.35, high ₹108.95, low ₹107.35
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹523 Cr2,703rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 8.73
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.17
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 35
Arvaya Healthcare has 528 announcements on record, routine notices left out; 6 in the 30 days to 28 Oct 2026, the latest on 24 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Arvaya Healthcare quarterly results
The board met on 12 Aug 2026 to consider quarterly results
Notice filed 6 Aug 2026
Arvaya Healthcare annual reports, presentations and earnings calls
The company's own documents, latest first.Arvaya Healthcare financials, year by year
Annual reports30
- Annual report, year to Mar 202628 Aug 2026
- Annual report, year to Mar 202530 Jul 2025
- Annual report, year to Mar 202423 Aug 2024
- Annual report, year to Mar 202326 Aug 2023
- Annual report, year to Mar 202225 Aug 2022
25 earlier reports
- Annual report, year to Mar 202125 Aug 2021
- Annual report, year to Mar 202025 Nov 2020
- Annual report, year to Mar 20194 Oct 2019
- Annual report, year to Mar 20185 Oct 2018
- Annual report, year to Mar 20176 Sep 2017
- Annual report, year to Mar 201629 Sep 2016
- Annual report, year to Mar 20152 Dec 2015
- Annual report, year to Mar 201427 Aug 2014
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 2011Filing day not known
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2001Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Arvaya Healthcare share news and announcements
Newest first. Page 1 of 11.
Oct 2026
24 Oct · Announcement under Regulation 30 (LODR)-Allotment
19 Oct · Board meeting
Meeting on 24 Oct 2026
Sep 2026
19 Sep · Announcement Under Reg 30 For Incorporation Of Wholly Owned Subsidiary.
Aug 2026
28 Aug · Meeting
26 Aug · Board meeting
21 Aug · Board meeting
Meeting on 26 Aug 202616 Aug · Meeting
12 Aug · Announcement Under Regulation 30 Of LODR
12 Aug · Results
6 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
17 Jul · Meeting
11 Jul · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
11 Jul · Business
11 Jul · Announcement under Regulation 30 (LODR)-Issue of Securities
11 Jul · Announcement under Regulation 30 (LODR)-Raising of Funds
11 Jul · Board meeting
8 Jul · Announcement under Regulation 30 (LODR)-Change of Company Name
6 Jul · Board meeting
Meeting on 11 Jul 2026: rights issue of equity shares and preferential issue of shares1 Jul · Board meeting
Meeting on 4 Jul 2026
Jun 2026
29 Jun · Approval Letter For Re-Classification Of Shareholders Under Regulation 31A Of SEBI (LODR) Regulations, 2015.
May 2026
28 May · Results
21 May · Board meeting
Meeting on 28 May 2026: audited results12 May · Announcement under Regulation 30 (LODR)-Change of Company Name
Apr 2026
28 Apr · Board Resolution Passed Through Circular Dated 28 April 2026.
21 Apr · Meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 23 Mar 2026Board or managers changed–market median 0.0% · volume 1.1× usual · The announcement
- 1 Dec 2025Board or managers changed0.00%−1.0 pts vs Nifty 500market median 0.0% · volume 0.9× usual · The announcement
- 10 Nov 2025Board or managers changed0.00%+0.9 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+1.2 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 1 Aug 2024Board or managers changed–market median 0.0% · volume 0.0× usual · The announcement
- 6 Jun 2023Board or managers changed–market median 0.0% · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Earnings per share, continuing businesses | Year to date to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |
| Earnings per share, continuing businesses | Quarter to Mar 2026 | Consolidated | 0.26 | 1.25 | +380.8% | 28 May 2026 | 3 Jun 2026 |
| Earnings per share, continuing businesses | Year to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |
| Diluted earnings per share, continuing businesses | Year to date to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |
| Diluted earnings per share, continuing businesses | Quarter to Mar 2026 | Consolidated | 0.26 | 1.25 | +380.8% | 28 May 2026 | 3 Jun 2026 |
| Diluted earnings per share, continuing businesses | Year to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |
| Earnings per share | Year to date to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |
| Earnings per share | Quarter to Mar 2026 | Consolidated | 0.26 | 1.25 | +380.8% | 28 May 2026 | 3 Jun 2026 |
| Earnings per share | Year to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |
| Diluted earnings per share | Year to date to Mar 2026 | Consolidated | 0.15 | 0.69 | +360.0% | 28 May 2026 | 3 Jun 2026 |